US4235236A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Device for dispensing drug by combined diffusional and osmotic operations
Assignee: Alza Corp
•
Filing: 1979-02-12
•
Granted: 1980-11-25
•
Expires: 1999-02-12
Abstract
Abstract A device is disclosed for delivering an agent to an environment of use at a substantially constant rate over time. The device comprises a wall formed of a microporous material surrounding a compartment housing the agent and a thermodynamic member. The member comprises a film formed of an expandable, semipermeable material surrounding a means for expanding the member. The member can occupy any space-position in the compartment, and it also can be in contact with the wall. In operation, when the device is in the environment, agent is delivered from the device by diffusion through fluid-filled paths in the microporous wall, with external fluid simultaneously entering the compartment through the paths, also, fluid is imbibed by the member from fluid present in the compartment or directly across the wall causing it to expand, fill the compartment and continuously maintain agent in a substantially saturated state at the wall, thereby delivering agent at a substantially zero order rate of release from the device over a prolonged period of time.
Inventors
- 👤 Felix Theeuwes
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 12:08
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0002; A61K9/0004
Claims Analysis
Total Claims: 24
Claim 1
Independent Claim
110 words
A device for the controlled delivery of a beneficial agent to an environment of use, said device comprising: (a) a microporous wall having a plurality of micropaths through the wall, said microporous wall surrounding and defining: (b) a compartment; (c) a beneficial agent in the compartment; and, (d) an expandable member in the compartment, said member comprising a flexible, semipermeable film surrounding an osmotically effective solute, a gas generating couple, or a swellable polymer; and, (e) wherein, when the device is in operation in the environment of use, the device continuously delivers agent by combined diffusional and osmotic operations, to the environment of use over a prolonged period of time.
Claim 2
Independent Claim
110 words
A device for the controlled delivery of a beneficial agent to an environment of use, said device comprising: (a) a microporous wall having a plurality of micropaths through the wall, said microporous wall surrounding and defining: (b) a compartment; (c) a beneficial agent in the compartment; and, (d) an expandable member in the compartment, said member comprising a flexible, semipermeable film surrounding an osmotically effective solute, a gas generating couple, or a swellable polymer; and, (e) wherein, when the device is in operation in the environment of use, the device continuously delivers agent by combined diffusional and osmotic operations, to the environment of use over a prolonged period of time.
Claim 3
Dependent Claim
27 words
The device for the controlled delivery of a beneficial agent according to claim 1 wherein the micropaths in the wall are formed in the environment of use.
Claim 4
Dependent Claim
31 words
The device for the controlled delivery of a beneficial agent according to claim 1 wherein the agent is a drug selected from the group consisting of local and systemic acting drugs.
Claim 5
Dependent Claim
33 words
The device for the controlled delivery of a beneficial agent according to claim 1 wherein when the device is in the environment of use the micropaths fill with fluid present in the environment.
Claim 6
Dependent Claim
79 words
The device for the controlled delivery of the beneficial agent according to claim 4, wherein in operation, agent is delivered from the device by diffusion through the micropaths in the microporous wall, with the member in the compartment absorbing fluid from the compartment, expanding and continuously filling the compartment for substantially maintaining the concentration of agent in a saturated phase at the microporous wall, thereby delivering agent at a zero-order rate of release over a prolonged period of time.
Claim 7
Dependent Claim
42 words
A device for the controlled delivery of the beneficial agent according to claim 1 wherein the semipermeable film is made of a member selected from the group consisting essentially of a cellulose ester, cellulose ether, cellulose acylate, cellulose diacylate, and cellulose triacylate.
Claim 8
Dependent Claim
37 words
The device for the controlled delivery of the beneficial agent according to claim 1 wherein the agent is a drug and the device is sized, shaped, and adapted for orally administering the drug to the gastrointestinal tract.
Claim 9
Dependent Claim
34 words
The device for the controlled delivery of the beneficial agent according to claim 1 wherein the agent is a drug, and the device sized, shaped and structured for administering drug to a body passageway.
Claim 10
Dependent Claim
39 words
The device for the controlled delivery of the beneficial agent according to claim 1 wherein the swellable polymer is cross-linked and is a member selected from the group consisting of poly(hydroxylalkyl methacrylate), poly(acrylamide), poly(N-vinyl-2-pyrrolidone), anionic hydrogels and cationic hydrogels.
Claim 11
Dependent Claim
62 words
The device for the controlled delivery of the beneficial agent according to claim 1 wherein the gas generating couple comprises an acid selected from the group consisting of malic, fumaric, tartaric, itaconic, citric, succinic, adipic and mesaconic, and a basic compound selected from the group consisting of lithium carbonate, sodium carbonate, potassium carbonate, lithium bicarbonate, potassium bicarbonate, sodium bicarbonate, and magnesium bicarbonate.
Claim 12
Dependent Claim
21 words
The device for the controlled delivery of the beneficial agent according to claim 1 wherein the semipermeable film contains a plasticizer.
Claim 13
Dependent Claim
43 words
The device for the controlled delivery of the beneficial agent according to claim 1 wherein the microporous wall is from a microporous polymer selected from the group consisting of poly(urethane), poly(imides), poly(benzimidazoles), cross-linked poly(vinylpyrrolidone), poly(amides), poly(sulfones), poly(saccharides) and poly(saccharides having substituted anhydroglucose units.
Claim 14
Dependent Claim
35 words
The device for the controlled delivery of the beneficial agent according to claim 1 wherein the micropaths in the wall are formed by removing a pore-former having a size of about 0.1 to 200 microns.
Claim 15
Dependent Claim
49 words
The device for the controlled delivery of the beneficial agent according to claim 1 wherien the micropaths in the wall are formed by removing a member selected from the group consisting of an alkali metal salt and an alkaline earth metal salt, a carbohydrate, a polymer, and mixtures thereof.
Claim 16
Dependent Claim
41 words
The device for the controlled delivery of the beneficial agent according to claim 1, wherein the agent is a drug, the environment is the ano-rectal passageway, and the device is sized, shaped and designed for delivering the drug to said environment.
Claim 17
Dependent Claim
23 words
The device for the controlled delivery of the beneficial agent according to claim 1 wherein the member imbibs fluid present in the compartment.
Claim 18
Dependent Claim
27 words
The device for the controlled delivery of the beneficial agent according to claim 1 wherein the member imbibs fluid across the wall from the environment of use.
Claim 19
Independent Claim
162 words
A method for the controlled administration of a beneficial drug to the anto-rectal passageway, which method comprises: A. inserting into the ano-rectal passageway a device that releases drug by a combination of diffusional and osmotic operations, wherein the device comprises: (1) a microporous wall having a plurality of micropaths through the wall, which microporous wall surrounds and defines; (2) a compartment; (3) a beneficial drug in the compartment; and, (4) an expandable member in the compartment, said member comprising a flexible, semipermeable film surrounding an osmotically effective solute, a gas generating couple, or a swellable polymer; B. admitting fluid from the ano-rectal passageway through the microporous wall into the compartment to form a solution containing drug, and for activating the member to osmotically imbibe fluid from within the compartment, increase in volume and supply the solution to the microporous wall; thereby, C. delivering drug through the microporous wall by the combined operations to the ano-retal passageway over a prolonged period of time.
Claim 20
Independent Claim
162 words
A method for the controlled administration of a beneficial drug to the anto-rectal passageway, which method comprises: A. inserting into the ano-rectal passageway a device that releases drug by a combination of diffusional and osmotic operations, wherein the device comprises: (1) a microporous wall having a plurality of micropaths through the wall, which microporous wall surrounds and defines; (2) a compartment; (3) a beneficial drug in the compartment; and, (4) an expandable member in the compartment, said member comprising a flexible, semipermeable film surrounding an osmotically effective solute, a gas generating couple, or a swellable polymer; B. admitting fluid from the ano-rectal passageway through the microporous wall into the compartment to form a solution containing drug, and for activating the member to osmotically imbibe fluid from within the compartment, increase in volume and supply the solution to the microporous wall; thereby, C. delivering drug through the microporous wall by the combined operations to the ano-retal passageway over a prolonged period of time.
Claim 21
Dependent Claim
56 words
The method for the controlled administration of a beneficial drug to the ano-rectal passageway according to claim 18 wherein the drug housed in the compartment is a member selected from the group consisting of acetarsol, adrenaline with benzocain, aminophylline, aminophylline with pentobarbital sodium, ampicillin, aspirin, benzocaine, biscodyl, bismuth subgallate, ergotamine tartrate, chloropromazine, isoprenaline, metronidazole, and thiethylperazine.
Claim 22
Independent Claim
157 words
A method for the controlled administration of a beneficial drug to the vagina, which method comprises: A. inserting into the vagina a device that release drug by a combination of diffusional and osmotic operations, wherein the device comprises: (1) a microporous wall having a plurality of micropaths through the wall, which microporous wall surrounds and defines; (2) a compartment; (3) a beneficial drug in the compartment; and, (4) an expandable member in the compartment, said member comprising a flexible, semipermeable film surrounding an osmotically effective solute, a gas generating couple, or a swellable polymer; B. admitting fluid from the vagina through the microporous wall into the compartment to form a solution containing drug, and for activating the member to osmotically imbibe fluid from within the compartment, increase in volume and supply solution to the microporous wall; thereby, C. delivering drug through the microporous wall by the combined operations to the vagina over a prolonged period of time.
Claim 23
Independent Claim
157 words
A method for the controlled administration of a beneficial drug to the vagina, which method comprises: A. inserting into the vagina a device that release drug by a combination of diffusional and osmotic operations, wherein the device comprises: (1) a microporous wall having a plurality of micropaths through the wall, which microporous wall surrounds and defines; (2) a compartment; (3) a beneficial drug in the compartment; and, (4) an expandable member in the compartment, said member comprising a flexible, semipermeable film surrounding an osmotically effective solute, a gas generating couple, or a swellable polymer; B. admitting fluid from the vagina through the microporous wall into the compartment to form a solution containing drug, and for activating the member to osmotically imbibe fluid from within the compartment, increase in volume and supply solution to the microporous wall; thereby, C. delivering drug through the microporous wall by the combined operations to the vagina over a prolonged period of time.
Claim 24
Dependent Claim
59 words
The method for the controlled administration of a beneficial drug to the vagina according to claim 20 wherein the drug housed in the vagina is a member selected from the group consisting essentially of allantorn, amenoarridine hydrochloride, benzocaine, benzalkonium chloride, candicidin, dienestrol, dibucaine, ephedrine sulfate, furazolidone, gentain violet, hydrocortisone, methylbenzethium chloride, phenylmercuric acetate, providone-iodine, sulfanilamide, sulfisoxazole, tetracaine, and undecylenates.
References Cited (Backward Citations)
US3993072A
Cited
US4060084A
Cited
US4111202A
Cited
US4111203A
Cited
US4111201A
Cited
US4127127A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-11-25 | 1984-05-26 | 1984-11-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-11-25 | 1988-05-26 | 1988-11-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-11-25 | 1992-05-26 | 1992-11-25 | $7700.00 | Window Closed / Lapsed |